Literature DB >> 4197747

Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease.

F J Dudley, M J O'Shea, A Ajdukiewicz, S Sherlock.   

Abstract

Serum immunoglobulin G, A, and M and serum antinuclear, mitochondrial, and smooth muscle antibody have been measured in 223 patients with hepatitis-associated antigen (HAA)-positive and -negative acute and chronic liver disease. In patients with acute hepatitis, chronic persistent hepatitis, and primary liver cell carcinoma, these indices failed to show any significant differences. However, in the group with chronic aggressive hepatitis the patients who were HAA negative had significantly higher levels of serum IgG, much higher titres of smooth muscle antibody, and often antinuclear and mitochondrial antibodies which were not found in the HAA-positive patients from this group. This suggests that different pathogenic mechanisms may be operative in HAA-positive and -negative chronic aggressive hepatitis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4197747      PMCID: PMC1412696          DOI: 10.1136/gut.14.5.360

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  24 in total

1.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

2.  Australia antigen and smooth-muscle antibody in acute and chronic hepatitis.

Authors:  R Wright
Journal:  Lancet       Date:  1970-03-07       Impact factor: 79.321

3.  Viral hepatitis. New light on an old disease.

Authors:  S Krugman; J P Giles
Journal:  JAMA       Date:  1970-05-11       Impact factor: 56.272

4.  Immunoglobulins in chronic liver disease.

Authors:  T Feizi
Journal:  Gut       Date:  1968-04       Impact factor: 23.059

5.  Viral hepatitis. Immunoglobulin response during the course of the disease.

Authors:  J P Giles; S Krugman
Journal:  JAMA       Date:  1969-04-21       Impact factor: 56.272

6.  Hepatitis-associated antigen in chronic liver disease.

Authors:  R A Fox; S P Niazi; S Sherlock
Journal:  Lancet       Date:  1969-09-20       Impact factor: 79.321

7.  Australia antigen in acute and chronic liver disease.

Authors:  R Wright; R W McCollum; G Klatskin
Journal:  Lancet       Date:  1969-07-19       Impact factor: 79.321

8.  An antigen detected in the blood during the incubation period of serum hepatitis.

Authors:  A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1968-07       Impact factor: 11.205

9.  Relation of Australia-SH antigen to the willowbrook MS-2 strain.

Authors:  J P Giles; R W McCollum; L W Berndtson; S Krugman
Journal:  N Engl J Med       Date:  1969-07-17       Impact factor: 91.245

10.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

View more
  8 in total

Review 1.  The immunology of liver disorders.

Authors:  G Walker
Journal:  Proc R Soc Med       Date:  1974-06

Review 2.  Chronic hepatitis.

Authors:  S Sherlock
Journal:  Gut       Date:  1974-07       Impact factor: 23.059

3.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

4.  Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance.

Authors:  P Kurki; A Miettinen; E Linder; P Pikkarainen; M Vuoristo; M P Salaspuro
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

5.  Liver disease--a prominent cause of serum IgE elevation.

Authors:  E Van Epps; G Husby; R C Williams; R G Strickland
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

6.  Double-stranded DNA-binding capacity of serum in acute and chronic liver disease.

Authors:  S Jain; R Markham; H C Thomas; S Sherlock
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

7.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

8.  In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. Dysfunction of spontaneous cell-mediated cytotoxicity in primary biliary cirrhosis.

Authors:  J M Vierling; D L Nelson; W Strober; D M Bundy; E A Jones
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.